# Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With Hypothermia

> **NCT04867993** · NA · UNKNOWN · sponsor: **University of Sarajevo** · enrollment: 80 (estimated)

## Conditions studied

- Asphyxia Neonatorum

## Interventions

- **DRUG:** Amikacin

## Key facts

- **NCT ID:** NCT04867993
- **Lead sponsor:** University of Sarajevo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-28
- **Primary completion:** 2022-08
- **Final completion:** 2022-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-04-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867993, "Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With Hypothermia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04867993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*